Product Information

AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.3424 per EA under NDC 33342019310. Its NADAC has been published 493 times since Jan 18, 2017.

AMLODIPINE-OLMESARTAN 10-40 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.3424per EA

Strength

10; 40 mg/1; mg/1

NDC

33342019310

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 493 times since Jan 18, 2017, and over the history we have for it it has declined 67.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3424 per EA
All-time high$1.1664 (Mar 15, 2017)
All-time low$0.2641 (Jan 17, 2024)
52-week high$0.3809
52-week low$0.3156
Median price$0.5229
Average price$0.5865
Largest weekly change+47.0% (Nov 22, 2023)
Weeks tracked493
Tracking sinceJan 18, 2017

Price History

1W

0.0%

1M

+0.4%

3M

-3.0%

6M

+0.5%

1Y

-5.6%

3Y

-21.6%

5Y

-37.1%

All

-67.0%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.3424 per EA (NDC 33342019310), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has declined 67.0%. It has been tracked across 493 weekly CMS publications since Jan 18, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?

Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.2641 (Jan 17, 2024) to a high of $1.1664 (Mar 15, 2017), with a median of $0.5229 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-40 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?

AMLODIPINE-OLMESARTAN 10-40 MG (NDC 33342019310) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.